Summary
44.08 0.15(0.34%)05/14/2024
Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (TNDM)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.28 | 19.82 | 31.20 | 88.06 | 170.63 | 31.59 | -32.48 | -77.15 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 44.01 | |
| Open | 43.64 | |
| High | 44.98 | |
| Low | 43.57 | |
| Volume | 1,221,080 | |
| Change | 0.56 | |
| Change % | 1.28 | |
| Avg Volume (20 Days) | 1,456,866 | |
| Volume/Avg Volume (20 Days) Ratio | 0.84 | |
| 52 Week Range | 13.82 - 47.00 | |
| Price vs 52 Week High | -6.37% | |
| Price vs 52 Week Low | 218.42% | |
| Range | 0.84 | |
| Gap Up/Down | -1.82 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2,837 | |
| EBIDTA | -138,748,192 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 35.93 | |
| Book Value | 4.7840 | |
| Earnings Per Share | -3.4300 | |
| EPS Estimate Current Quarter | -0.2500 | |
| EPS Estimate Next Quarter | -0.4700 | |
| EPS Estimate Current Year | -1.5900 | |
| EPS Estimate Next Year | -1.0900 | |
| Diluted EPS (TTM) | -3.4300 | |
| Revenues | ||
| Profit Marging | -0.2977 | |
| Operating Marging (TTM) | -0.1781 | |
| Return on asset (TTM) | -0.0963 | |
| Return on equity (TTM) | -0.5908 | |
| Revenue TTM | 747,718,016 | |
| Revenue per share TTM | 11.5090 | |
| Quarterly Revenue Growth (YOY) | -0.1080 | |
| Quarterly Earnings Growth (YOY) | -0.3700 | |
| Gross Profit (TTM) | 412,986,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 1,111.1111 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 6.8962 | |
| Revenue Enterprise Value | 2.8228 | |
| EBITDA Enterprise Value | -10.7153 | |
| Shares | ||
| Shares Outstanding | 64,563,500 | |
| Shares Float | 59,855,509 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.63 | |
| Institutions (%) | 110.74 | |
05/03 16:34 EST - The Motley Fool
Why Tandem Diabetes Stock Just Jumped 22%
Tandem Diabetes Care beat earnings -- but only by losing less money than expected -- on Thursday. On the plus side, sales jumped much higher than expected.
Why Tandem Diabetes Stock Just Jumped 22%
Tandem Diabetes Care beat earnings -- but only by losing less money than expected -- on Thursday. On the plus side, sales jumped much higher than expected.
05/03 10:36 EST - Zacks Investment Research
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
Tandem Diabetes (TNDM) outperforms in the first quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
Tandem Diabetes (TNDM) outperforms in the first quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.
05/02 19:31 EST - Zacks Investment Research
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/02 18:31 EST - Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.63 per share a year ago.
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.63 per share a year ago.
04/09 16:05 EST - Business Wire
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results. A live webcast of the call will be available on Tandem Diabetes.
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results. A live webcast of the call will be available on Tandem Diabetes.
04/07 12:07 EST - The Motley Fool
1 Beaten-Down Stock That Could Make You Richer
Tandem Diabetes Care is facing economic issues affecting its financial results. The company has the tools to bounce back, including a recently launched device.
1 Beaten-Down Stock That Could Make You Richer
Tandem Diabetes Care is facing economic issues affecting its financial results. The company has the tools to bounce back, including a recently launched device.
04/01 11:46 EST - Zacks Investment Research
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.
03/26 15:05 EST - The Motley Fool
Why Tandem Diabetes Care Stock Was Zooming Higher Today
An analyst upgraded his recommendation on the diabetes care specialist. He now rates it a buy, with potential 11% upside to the current share price.
Why Tandem Diabetes Care Stock Was Zooming Higher Today
An analyst upgraded his recommendation on the diabetes care specialist. He now rates it a buy, with potential 11% upside to the current share price.
03/22 13:26 EST - Zacks Investment Research
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.
03/22 12:36 EST - Zacks Investment Research
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock?
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock?
03/20 16:30 EST - InvestorPlace
Shhh! 7 Small-Cap Stocks That Can Double by 2025
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small.
Shhh! 7 Small-Cap Stocks That Can Double by 2025
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small.
03/19 09:16 EST - Zacks Investment Research
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
03/08 07:21 EST - Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains?
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains?
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
02/22 18:55 EST - The Motley Fool
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter.
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter.
02/22 09:36 EST - Zacks Investment Research
Tandem Diabetes (TNDM) Posts Wider Q4 Loss, Gross Margin Down
Tandem Diabetes (TNDM) reports a higher-than-expected loss in the fourth quarter of 2023.
Tandem Diabetes (TNDM) Posts Wider Q4 Loss, Gross Margin Down
Tandem Diabetes (TNDM) reports a higher-than-expected loss in the fourth quarter of 2023.
02/21 22:47 EST - Seeking Alpha
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
02/21 19:01 EST - Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
02/21 18:26 EST - Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.01 per share a year ago.
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.01 per share a year ago.
02/15 10:26 EST - Zacks Investment Research
Tandem (TNDM) Broadens Insulin Pumps Line in the U.S. With Mobi
Tandem's (TNDM) Mobi is claimed to be the world's smallest durable automated insulin delivery system.
Tandem (TNDM) Broadens Insulin Pumps Line in the U.S. With Mobi
Tandem's (TNDM) Mobi is claimed to be the world's smallest durable automated insulin delivery system.
02/14 11:06 EST - Zacks Investment Research
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Expected to Decline
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Expected to Decline
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.